Ashley Gallagher

Thomas Sherrer, PharmD, emphasizes the importance of a team-based approach to inventory control.

Buddy Carter, PBM, US Representative (R-GA), emphasizes the critical role of pharmacists, particularly during the COVID-19 pandemic, and advocates for provider status recognition.

Pharmacists can transform from only being prescription dispensers to health care hubs that offer comprehensive patient care and generate innovative revenue streams.

The key theme, regardless of strategy, is being an engaging member of the community and stepping outside of the counter.

Patients with a single cardiometabolic disease have an approximate 48% greater risk of developing all-cause dementia compared with those without a cardiometabolic disease.

Efsitora demonstrates noninferior reductions in hemoglobin A1c and similar rates of patients with an A1c of less than 7% compared with common daily insulin.

This year’s conference is taking place from July 10 to 13 in Nashville, Tennessee.

Investigators also report that sodium-glucose cotransporter 2 inhibitors are not associated with thrombotic risk.

Health care professionals emphasize patient education and reliable information in the evolving vaccine recommendation landscape.

Kevin Cleveland, PharmD, urges evidence-based approaches to immunizations in an era of uncertainty.

Cherokee Layson-Wolf, PharmD, BCACP, FAPhA, discusses the impact of shifting guidance on vaccination strategies.

As concerns mount over potential shifts in vaccine recommendations, Deanna Tran, PharmD, BCACP, FAPhA, advocates for rigorous data assessment and patient-centered communication strategies.

Pharmacist-led deprescribing can help reduce the number of medications a patient is taking in an effective way.

Interest in community pharmacy practice is declining as pharmacists seek roles with better work-life balance, greater autonomy, and more meaningful patient care opportunities.

Pharmacists play a role in educating patients as well as making them feel more comfortable when utilizing opioid use treatment.

Of those who do not support vaccines, 79% said a major reason for their opposition is that it should be the parents’ choice about whether to vaccinate their child and 40% cite safety concerns.

Clinical pharmacists transform diabetes care by leveraging manufacturer-sponsored patient assistance programs to dramatically improve medication access.

An ambulatory care pharmacist program in Washington State dramatically improved diabetes management by reducing A1c levels, increasing medication adherence, and providing comprehensive patient education.

ACIP also discusses COVID-19 epidemiology as well as safety and efficacy for the COVID-19 vaccines.

CD388 is being investigated as a prevention method for seasonal influenza in unvaccinated patients aged 18 to 64 years.

Nathan Ramsbacher, PharmD, emphasizes that one of the most significant barriers to clinical quality is patients' inability to access crucial medications due to cost.

The most frequent barriers to access to glucagon include cost, patient health literacy, and insurance coverage.

The initiative focuses on managing medications for high-risk diabetes patients through a collaborative drug therapy agreement.

Thimerosal is a mercury-containing compound that has been widely used as a preservative in some biological and drug products since the 1930s.

Revita is a procedure that modifies duodenal dysfunction and restores metabolic health, according to Fractyl Health.

This approval offers pediatric patients and caregivers the first subcutaneous option that can be administered at home.

In a real-world, 6-month analysis, glucagon-like peptide-1 programs with obesity telemedicine behavioral programs resulted in benefits to weight loss and blood pressure.

When compared with adults 45 years and older, those 18 to 44 years are less likely to receive treatment or achieve target goals for cardiometabolic risk factors.

Kevin Cleveland, PharmD, discusses how pharmacists are uniquely positioned to provide immediate, direct interactions with patients, making them vital in addressing vaccine misinformation.

Investigators assessed continuous glucose monitoring with behavioral intervention for patients with type 1 diabetes.